Troxacitabine
WikiDoc Resources for Troxacitabine |
Articles |
---|
Most recent articles on Troxacitabine Most cited articles on Troxacitabine |
Media |
Powerpoint slides on Troxacitabine |
Evidence Based Medicine |
Clinical Trials |
Ongoing Trials on Troxacitabine at Clinical Trials.gov Trial results on Troxacitabine Clinical Trials on Troxacitabine at Google
|
Guidelines / Policies / Govt |
US National Guidelines Clearinghouse on Troxacitabine NICE Guidance on Troxacitabine
|
Books |
News |
Commentary |
Definitions |
Patient Resources / Community |
Patient resources on Troxacitabine Discussion groups on Troxacitabine Patient Handouts on Troxacitabine Directions to Hospitals Treating Troxacitabine Risk calculators and risk factors for Troxacitabine
|
Healthcare Provider Resources |
Causes & Risk Factors for Troxacitabine |
Continuing Medical Education (CME) |
International |
|
Business |
Experimental / Informatics |
Please Take Over This Page and Apply to be Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [1] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.
Overview
Troxacitabine (brand name Troxatyl) is a nucleoside analogue with anticancer activity. Its use is being studied in patients with refractory lymphoproliferative diseases.